IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $339 | -23.3% | 21,362 | -8.8% | 0.00% | 0.0% |
Q2 2023 | $442 | +124.4% | 23,433 | -54.4% | 0.00% | +100.0% |
Q1 2023 | $197 | -21.8% | 51,401 | +1.3% | 0.00% | 0.0% |
Q4 2022 | $252 | -99.9% | 50,765 | -5.0% | 0.00% | 0.0% |
Q3 2022 | $256,000 | +6.2% | 53,463 | -0.2% | 0.00% | 0.0% |
Q2 2022 | $241,000 | +81.2% | 53,563 | +91.5% | 0.00% | 0.0% |
Q1 2022 | $133,000 | -35.7% | 27,974 | +0.4% | 0.00% | 0.0% |
Q4 2021 | $207,000 | +95.3% | 27,875 | +49.2% | 0.00% | 0.0% |
Q3 2021 | $106,000 | -5.4% | 18,687 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $112,000 | +55.6% | 17,373 | -12.5% | 0.00% | – |
Q3 2020 | $72,000 | -20.9% | 19,866 | +0.5% | 0.00% | -100.0% |
Q2 2020 | $91,000 | +35.8% | 19,766 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $67,000 | -75.5% | 19,766 | +7.7% | 0.00% | -90.0% |
Q1 2014 | $274,000 | +21.2% | 18,358 | +19.1% | 0.01% | +11.1% |
Q4 2013 | $226,000 | -9.6% | 15,408 | +4.8% | 0.01% | -18.2% |
Q3 2013 | $250,000 | +8.2% | 14,708 | +5.8% | 0.01% | -8.3% |
Q2 2013 | $231,000 | – | 13,908 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |